-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-6-a-cpqsc-hospitals.pdf
June 02, 2025 - Section 6-A, CPQSC Participating Hospitals
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-1-table-1.pdf
June 02, 2025 - Section 1, Table 1. Definitions of Three Levels of Medical Complexity
Table 1. COE…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-5a-research-evidence-table.pdf
January 01, 2011 - Section 5.A, Research Evidence Table
VA. Research Evidence - Table
Guidelines Found
Organization
(Year)
Care
Setting
Relevant
Population
Recommendation Grade*
AACAP
(2011)
Not
specified
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-217-section-7-table-8.pdf
June 02, 2025 - Section 7, Table 8
Table 8: Race/Ethnicity for Newborns with SCD in Michigan, 2004-2008 (n=294)
White
Non‐
Hispanic
White
Hispanic
White
Total
Black
Non‐
Hispanic
Black
Hispanic
Black
Total
Asian or
Pacific
Islander
Non‐
Hispanic
Asian or
Pacific
Islander
Hispanic
Asian or
Pacif…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-section-6-table-7.pdf
June 02, 2025 - Section 6, Table 7 Delphi Panel Members and Nominating Organizations
Table 7: Delphi panel members and nominating organizations
Richard Antonelli, MD, MS
Medical Director of Integrated Care and Strategic Partnerships
Medical Director Physician Relations and Outreach
Boston Children’s Hospital
Assistant Profe…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-section-6b-chart-1.pdf
June 02, 2025 - Section 6.B, Chart 1
Chart 1.
0.00
15.00
30.00
45.00
60.00
75.00
J F M A M J J A S O N D
Rate of Asthma ED Visits Across the Year
By Age Group
(Visits per 100 Child-Years)
2-3 4-6 7-11 12-18
We find these data and their consistency with expected findings to be
persuasive that…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-6-appendix-1.pdf
September 01, 2011 - Section 6, Appendix 1, Tables 1 to 4
Appendix 1. Guidelines and Measure-Specific Testing Results
Use of Higher-than-Recommended Doses of …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-6-figure-1.pdf
June 02, 2025 - Figure 1. Confirmatory Factor Analysis (CFA) Two-Factor Model Structure
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-7-table-9.pdf
June 02, 2025 - Table 9. Differences in ADAPT Survey Scores Based on Boston Children's Hospital Clinical Programs
Table 9:…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-7-table-8.pdf
June 02, 2025 - Table 8. Differences in ADAPT Survey Scores Based on Race/Ethnicity
Table 8: Differences in ADAPT su…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-7-table-10.pdf
June 02, 2025 - Section 7, Table 10
Table 10. Race/Ethnicity by Site for Children (Ages 0-18 years) with Sepsis Syndrome
Race/Ethnicity (%) Hospital 1
(n = 100)
Hospital 2
(n = 100)
Hospital 3
(n = 100)
White
Non-Hispanic
Hispanic
Unknown
Total
-
-
63
63
-
-
59
59
27
5
-
32
Black
Non-Hispanic …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-6-table-9.pdf
June 02, 2025 - Section 6, Tables 7-9
Table 9: Documentation of Heart Rate for Children with Severe Sepsis or Septic Shock
Site Numerator Denominator Rate
Hospital #1 3 11 27%
Hospital #2 0 2 0%
Hospital #3 0 4 0%
All Sites 3 17 18%
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-5-table-3.pdf
January 01, 2013 - Table 3. Evidence for Timely Bolus for Treatment of Children with Severe Sepsis of Septic Shock
Table 3: Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic
Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Pe…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-section-5-table-3.pdf
August 01, 2014 - Section 5, Table 3
Table 3: Evidence for Having a Protocol to Identify and Treat Children with Sepsis Syndrome in
the Emergency Department
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Recommendation: Performance
improvement efforts in severe sepsis
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-7-table-8.pdf
June 02, 2025 - Section 7, Table 8
Table 8. Race/Ethnicity by Site for Children (Ages 0-18 years) with Sepsis Syndrome
Race/Ethnicity (%) Hospital 1
(n = 100)
Hospital 2
(n = 100)
Hospital 3
(n = 100)
White
Non-Hispanic
Hispanic
Unknown
Total
-
-
63
63
-
-
59
59
27
5
-
32
Black
Non-Hispanic …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-5-table-6.pdf
January 01, 2013 - Section 5, Table 6
1
Table 6: Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic
Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking)
Citations
Clinical
guidelines
Pediatric considerations in severe sepsis:
In children, definitions of sepsis are…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-3-table-5.pdf
June 02, 2025 - Section 3, Table 5
Table 5. Ranges for Normal Heart Rates, by Age
Threshold (Normal) Ranges Age
Group
Heart Rates (beats/min)
Term newborn 120 to 180
Up to 1 year 120 to 180
Up to 2 years 120 to 160
Up to 7 years 100 to 140
Up to 15 years 90 to 140
(From Brierley et al., 2009)
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-5-table-4.pdf
January 01, 2014 - Table 4. Evidence for Prompt Antimicrobial Therapy for Treatment of Children With Severe Sepsis or Septic Shock
Table 4: Evidence for Prompt Antimicrobial Therapy for Treatment of Children with Severe Sepsis or Septic Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
C…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-6-table-4.pdf
June 02, 2025 - Table 4. Percent Agreement and Kappa Statistics for Sepsis for Inter-Rater Reliability at Three Study Sites
Table 4: Percent Agreement and Kappa Statistics for Sepsis for Inter-Rater Reliability at Three
Study Sites
Site Eligibility Criteria/
Measure Numerator
Number of
Records
R i d
N Agreed (%) Kappa
St…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-7a-table-7.pdf
June 02, 2025 - Section 7.A, Table 7
Table 7: Race/Ethnicity by Site for Children (Ages 0 through 18 years) with Sepsis Syndrome
Hospital White Black Asian or Pacific
Islander
Other or Unknown
Non-
Hispanic
Hispanic Unknown Total Non-
Hispanic
Hispanic Unknown Total Non-
Hispanic
Hispanic Unknown Tot…